Start for free

Krsnaa Diagnostics Limited

NSE: KRSNAAHealthcare

Krsnaa Diagnostics Limited Share Price & Analysis

₹560.00+1.64%Updated 4 Sept 2026, 03:30 pm IST
LTP
₹560.00+1.64%
Open
₹552.35
High
₹564.40
Low
₹550.05
Close
₹560.00
52W High
₹894.40
52W Low
₹502.00
Volume
21K
Lot Size
1
Sector
Healthcare
Market Cap
₹2K Cr
Face Value
₹5
Small Cap

Price Chart

Candle
Range

Fundamentals

P/E
18.60
Sector P/E
54.70
P/B
1.87
EPS
₹24.81
ROE
10.90%
ROCE
12.70%
D/E Ratio
0.54
Div Yield
0.36%
Book Value
₹302.00

Strengths

  • Attractively valued vs sector (P/E 18.6x vs industry 54.7x)
  • Near 52-week low — potential value zone (₹502)

Concerns

    Peer Comparison

    CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
    SUNPHARMA
    Sun Pharmaceutical Industries Limited
    ₹1,899
    		₹4.6L Cr36.15.461620.50.07
    DIVISLAB
    Divi's Laboratories Limited
    ₹9,100
    		₹2.4L Cr81.114.4216.5220.01
    TORNTPHARM
    Torrent Pharmaceuticals Limited
    ₹4,857
    		₹1.8L Cr82.819.5827.415.20.33
    APOLLOHOSP
    Apollo Hospitals Enterprise Limited
    ₹8,650
    		₹1.2L Cr59.113.1321.217.40.88
    CIPLA
    Cipla Limited
    ₹1,385
    		₹1.1L Cr31.33.2511.615.50.01
    ZYDUSLIFE
    Zydus Lifesciences Limited
    ₹1,120
    		₹1.1L Cr234.1621.221.10.38
    LAURUSLABS
    Laurus Labs Limited
    ₹1,840
    		₹99K Cr90.918.7418.317.80.46

    Showing 7 peers in the same sector · Sorted by market cap

    Shareholding Pattern

    KRSNAA · as of Mar 2026

    Promoters27.24%
    FII3.55%0.49pp
    DII14.26%0.20pp
    Public54.94%0.67pp
    CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
    Promoters27.03%27.03%27.17%27.17%27.24%27.24%
    FII3.44%3.34%3.33%3.63%4.04%3.55%
    DII16.59%15.37%15.26%15.86%14.46%14.26%
    Public52.94%54.27%54.23%53.34%54.27%54.94%

    Corporate Events

    To consider and approve the financial results for the period ended March 31, 2026 and dividend

    Dividend24 May 2026

    Dividend - Rs 2.75 Per Share

    Dividend11 Sept 2025

    Dividend - Rs 2.50 Per Share

    Dividend12 Sept 2024

    Annual General Meeting

    AGM12 Sept 2024

    Annual General Meeting

    AGM14 Sept 2023

    Dividend - Rs 2.75 Per Share

    Dividend14 Sept 2023

    Latest News

    All news

    Krsnaa Diagnostics publishes mandatory newspaper notice

    *Krsnaa Diagnostics publishes mandatory newspaper notice.* This is a routine regulatory requirement under corporate norms. No financial or operational details were disclosed. Such filings are standard for public disclosures. 📊 *STOCKS:* KRISANA | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #CorporateFiling

    NSE Filing4d ago
    Low Impact

    Krsnaa Diagnostics issues general corporate updates

    *Krsnaa Diagnostics issues general corporate updates.* The filing provides routine information without disclosing specific financials or strategic moves. Such updates typically do not alter business fundamentals. Investors await further clarity on operations or governance. 📊 *STOCKS:* KRISANA | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Corporate

    NSE Filing20 Aug
    Low Impact

    Krsnaa Diagnostics shares up on investor presentation

    *Krsnaa Diagnostics shares rose after an investor presentation.* The update highlighted **₹1,100 crore** revenue run rate and expansion plans. No major financial surprises or guidance changes were announced. The stock reacted positively despite no immediate triggers. 📊 *STOCKS:* KRISANA | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #InvestorPresentation

    NSE Filing14 Aug
    Low Impact

    Financials

    Quarterly Results

    MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    Revenue
    ₹181 Cr
    12.1%
    ₹206 Cr
    6.7%
    ₹193 Cr
    3.8%
    ₹186 Cr
    6.3%
    ₹175 Cr
    5.9%
    ₹186 Cr
    9.4%
    ₹170 Cr
    2.4%
    ₹166 Cr
    Op. Profit
    ₹46 Cr
    22.0%
    ₹59 Cr
    15.7%
    ₹51 Cr
    3.8%
    ₹53 Cr
    17.8%
    ₹45 Cr
    8.2%
    ₹49 Cr
    14.0%
    ₹43 Cr
    2.3%
    ₹44 Cr
    OPM
    26.0%
    10.3%
    29.0%
    7.4%
    27.0%
    3.6%
    28.0%
    7.7%
    26.0%
    3.7%
    27.0%
    8.0%
    25.0%
    3.8%
    26.0%
    Net Profit
    ₹15 Cr
    37.5%
    ₹24 Cr
    14.3%
    ₹21 Cr
    0.0%
    ₹21 Cr
    10.5%
    ₹19 Cr
    5.0%
    ₹20 Cr
    11.1%
    ₹18 Cr
    5.3%
    ₹19 Cr
    EPS (₹)
    4.7
    36.3%
    7.38
    16.6%
    6.33
    1.1%
    6.4
    6.5%
    6.01
    1.0%
    6.07
    9.4%
    5.55
    4.3%
    5.8

    Values in ₹ Cr · Source: Screener.in

    Annual Profit & Loss

    MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2017Mar 2016
    Revenue
    ₹773 Cr
    7.8%
    ₹717 Cr
    15.6%
    ₹620 Cr
    27.3%
    ₹487 Cr
    7.0%
    ₹455 Cr
    645.9%
    ₹61 Cr
    56.4%
    ₹39 Cr
    Expenses
    ₹561 Cr
    6.5%
    ₹527 Cr
    10.9%
    ₹475 Cr
    30.1%
    ₹365 Cr
    12.7%
    ₹324 Cr
    671.4%
    ₹42 Cr
    40.0%
    ₹30 Cr
    Op. Profit
    ₹212 Cr
    11.6%
    ₹190 Cr
    31.9%
    ₹144 Cr
    18.0%
    ₹122 Cr
    7.6%
    ₹132 Cr
    594.7%
    ₹19 Cr
    111.1%
    ₹9 Cr
    OPM
    27.0%
    0.0%
    27.0%
    17.4%
    23.0%
    8.0%
    25.0%
    13.8%
    29.0%
    6.5%
    31.0%
    34.8%
    23.0%
    Other Income
    ₹43 Cr
    65.4%
    ₹26 Cr
    52.9%
    ₹17 Cr
    10.5%
    ₹19 Cr
    26.7%
    ₹15 Cr
    650.0%
    ₹2 Cr
    33.3%
    ₹3 Cr
    Interest
    ₹34 Cr
    36.0%
    ₹25 Cr
    56.3%
    ₹16 Cr
    100.0%
    ₹8 Cr
    55.6%
    ₹18 Cr
    100.0%
    ₹9 Cr
    0.0%
    ₹9 Cr
    Depreciation
    ₹90 Cr
    2.3%
    ₹88 Cr
    17.3%
    ₹75 Cr
    38.9%
    ₹54 Cr
    31.7%
    ₹41 Cr
    241.7%
    ₹12 Cr
    100.0%
    ₹6 Cr
    PBT
    ₹130 Cr
    26.2%
    ₹103 Cr
    47.1%
    ₹70 Cr
    12.5%
    ₹80 Cr
    8.0%
    ₹87 Cr
    ₹0 Cr
    100.0%
    ₹-3 Cr
    Tax %
    22.0%
    8.3%
    24.0%
    26.3%
    19.0%
    17.4%
    23.0%
    9.5%
    21.0%
    88.3%
    180.0%
    267.3%
    49.0%
    Net Profit
    ₹101 Cr
    29.5%
    ₹78 Cr
    36.8%
    ₹57 Cr
    8.1%
    ₹62 Cr
    8.8%
    ₹68 Cr
    ₹0 Cr
    100.0%
    ₹-5 Cr
    EPS (₹)
    31.27
    30.1%
    24.04
    36.6%
    17.6
    11.0%
    19.78
    9.2%
    21.78
    15657.1%
    -0.14
    98.5%
    -9.53
    Div Payout
    0.0%
    100.0%
    11.0%
    21.4%
    14.0%
    0.0%
    14.0%
    27.3%
    11.0%
    0.0%
    0.0%

    Values in ₹ Cr · Source: Screener.in

    Balance Sheet

    ItemMar 2026Sep 2025Mar 2025Mar 2024Mar 2023Mar 2022Mar 2017Mar 2016
    Liabilities
    Equity Capital
    ₹16 Cr
    0.0%
    ₹16 Cr
    0.0%
    ₹16 Cr
    0.0%
    ₹16 Cr
    0.0%
    ₹16 Cr
    0.0%
    ₹16 Cr
    220.0%
    ₹5 Cr
    0.0%
    ₹5 Cr
    Reserves
    ₹964 Cr
    6.3%
    ₹907 Cr
    4.6%
    ₹867 Cr
    9.2%
    ₹794 Cr
    9.8%
    ₹723 Cr
    8.1%
    ₹669 Cr
    11050.0%
    ₹6 Cr
    0.0%
    ₹6 Cr
    Borrowings
    ₹534 Cr
    86.7%
    ₹286 Cr
    40.2%
    ₹204 Cr
    27.5%
    ₹160 Cr
    400.0%
    ₹32 Cr
    22.0%
    ₹41 Cr
    59.8%
    ₹102 Cr
    22.1%
    ₹131 Cr
    Other Liabilities
    ₹309 Cr
    3.7%
    ₹298 Cr
    55.2%
    ₹192 Cr
    4.5%
    ₹201 Cr
    46.7%
    ₹137 Cr
    8.7%
    ₹150 Cr
    87.5%
    ₹80 Cr
    81.8%
    ₹44 Cr
    Total Liabilities
    ₹1.8K Cr
    21.0%
    ₹1.5K Cr
    17.9%
    ₹1.3K Cr
    9.2%
    ₹1.2K Cr
    28.9%
    ₹908 Cr
    3.8%
    ₹875 Cr
    355.7%
    ₹192 Cr
    3.2%
    ₹186 Cr
    Assets
    Fixed Assets
    ₹656 Cr
    4.0%
    ₹683 Cr
    1.9%
    ₹670 Cr
    3.6%
    ₹647 Cr
    37.4%
    ₹471 Cr
    22.0%
    ₹386 Cr
    194.7%
    ₹131 Cr
    77.0%
    ₹74 Cr
    CWIP
    ₹208 Cr
    593.3%
    ₹30 Cr
    900.0%
    ₹3 Cr
    70.0%
    ₹10 Cr
    60.0%
    ₹25 Cr
    10.7%
    ₹28 Cr
    366.7%
    ₹6 Cr
    70.0%
    ₹20 Cr
    Investments
    ₹57 Cr
    78.1%
    ₹32 Cr
    0.0%
    ₹32 Cr
    ₹0 Cr
    ₹0 Cr
    ₹0 Cr
    100.0%
    ₹1 Cr
    0.0%
    ₹1 Cr
    Other Assets
    ₹902 Cr
    18.4%
    ₹762 Cr
    33.0%
    ₹573 Cr
    11.7%
    ₹513 Cr
    24.5%
    ₹412 Cr
    10.6%
    ₹461 Cr
    738.2%
    ₹55 Cr
    39.6%
    ₹91 Cr
    Total Assets
    ₹1.8K Cr
    21.0%
    ₹1.5K Cr
    17.9%
    ₹1.3K Cr
    9.2%
    ₹1.2K Cr
    28.9%
    ₹908 Cr
    3.8%
    ₹875 Cr
    355.7%
    ₹192 Cr
    3.2%
    ₹186 Cr

    Values in ₹ Cr · Source: Screener.in

    Cash Flow Statement

    ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2017Mar 2016
    Operating CF
    ₹143 Cr
    64.4%
    ₹87 Cr
    262.5%
    ₹24 Cr
    68.4%
    ₹76 Cr
    40.6%
    ₹128 Cr
    100.0%
    ₹64 Cr
    378.3%
    ₹-23 Cr
    Investing CF
    ₹-396 Cr
    296.0%
    ₹-100 Cr
    22.5%
    ₹-129 Cr
    18.3%
    ₹-109 Cr
    54.8%
    ₹-241 Cr
    346.3%
    ₹-54 Cr
    14.9%
    ₹-47 Cr
    Financing CF
    ₹279 Cr
    1892.9%
    ₹14 Cr
    83.3%
    ₹84 Cr
    354.5%
    ₹-33 Cr
    118.8%
    ₹176 Cr
    529.3%
    ₹-41 Cr
    139.0%
    ₹105 Cr
    Net Cash Flow
    ₹26 Cr
    2500.0%
    ₹1 Cr
    105.0%
    ₹-20 Cr
    69.7%
    ₹-66 Cr
    203.1%
    ₹64 Cr
    306.5%
    ₹-31 Cr
    186.1%
    ₹36 Cr
    Free Cash Flow
    ₹-72 Cr
    200.0%
    ₹-24 Cr
    85.8%
    ₹-169 Cr
    191.4%
    ₹-58 Cr
    1833.3%
    ₹-3 Cr
    130.0%
    ₹10 Cr
    114.5%
    ₹-69 Cr

    Values in ₹ Cr · Source: Screener.in

    Key Ratios History

    MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2017Mar 2016
    Debtor Days
    140d
    0.7%
    141d
    35.6%
    104d
    89.1%
    55d
    19.6%
    46d
    45.2%
    84d
    6.3%
    79d
    Inventory Days
    54d
    —
    —
    —
    —
    24d
    14.3%
    21d
    Days Payable
    129d
    —
    —
    —
    —
    100d
    31.6%
    76d
    Cash Conv. Cycle
    65d
    53.9%
    141d
    35.6%
    104d
    89.1%
    55d
    19.6%
    46d
    475.0%
    8d
    66.7%
    24d
    Working Capital Days
    48d
    128.6%
    21d
    200.0%
    -21d
    290.9%
    11d
    147.8%
    -23d
    79.6%
    -113d
    63.8%
    -69d
    ROCE
    13.0%
    8.3%
    12.0%
    20.0%
    10.0%
    16.7%
    12.0%
    —
    7.0%
    —

    Source: Screener.in · Lower days = better efficiency

    Related Analysis

    Same Sector

    ALKEMAlkem Laboratories LimitedNeutralAPOLLOHOSPApollo Hospitals Enterprise LimitedNeutralAUROPHARMAAurobindo Pharma LimitedNeutralBIOCONBiocon LimitedNeutralCIPLACipla LimitedNeutral

    Frequently Asked Questions

    What is Krsnaa Diagnostics Limited share price today?
    Krsnaa Diagnostics Limited (KRSNAA) is currently trading at ₹560 on NSE, up 1.64% as of the last market session. Prices update daily after market close on MarketNetra.
    Is Krsnaa Diagnostics Limited available in F&O (Futures & Options)?
    Yes, Krsnaa Diagnostics Limited (KRSNAA) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
    What is Krsnaa Diagnostics Limited 52-week high and low?
    Krsnaa Diagnostics Limited's 52-week high is ₹894.4 and the 52-week low is ₹502. The current price of ₹560 is 37.4% below the 52W high.
    What is Krsnaa Diagnostics Limited P/E ratio?
    Krsnaa Diagnostics Limited's current P/E ratio is 18.6. This indicates the market is paying ₹18.6 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
    How to trade Krsnaa Diagnostics Limited options?
    Krsnaa Diagnostics Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade KRSNAA options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.